Natco Drug Discovery Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 35 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Ebitda
- Net Worth -0.01%
- Total Assets -30.17%
About Natco Drug Discovery
Natco Drug Discovery Private Limited (NDDPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 May 1989 and has a history of 35 years and ten months. Its registered office is in Hyderabad, Telangana, India.
The Corporate was formerly known as Natchem Pharma Pvt Ltd.. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pathuri Rao and Sadasiva Nannapaneni serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230TG1989PTC009942
- Company No.
009942
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 May 1989
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Pharma
Who are the key members and board of directors at Natco Drug Discovery?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pathuri Rao  | Director | 19-Jun-2002 | Current |
| Sadasiva Nannapaneni | Director | 01-Jul-2016 | Current |
Financial Performance of Natco Drug Discovery.
Natco Drug Discovery Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 0.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Natco Drug Discovery?
In 2023, Natco Drug Discovery had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Time Cap Pharma Labs Private Limited
Sadasiva Nannapaneni is a mutual person
- Natco Power Private Limited
Sadasiva Nannapaneni is a mutual person
Ndl Infratech Private LimitedSadasiva Nannapaneni is a mutual person
- Natsoft Information Systems Private Limited
Sadasiva Nannapaneni is a mutual person
- Criterion Edge India Private Limited
Sadasiva Nannapaneni is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Natco Drug Discovery?
Unlock and access historical data on people associated with Natco Drug Discovery, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Natco Drug Discovery, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Natco Drug Discovery's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Natco Drug Discovery
Recent activity within the organization
- Annual General Meeting
Natco Drug Discovery Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Natco Drug Discovery Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
- Director Appointment
Sadasiva Rao Nannapaneni was appointed as a Director was appointed as a Director on 01 Jul 2016 & has been associated with this company since 8 years 8 months .
- Director Appointment
Pathuri Srinivasa Rao was appointed as a Director was appointed as a Director on 19 Jun 2002 & has been associated with this company since 22 years 8 months .
- Company Incorporation
Natco Drug Discovery Private Limited was registered on 02 May 1989 with Roc Hyderabad & aged 35 years 10 months as per MCA records.
Recent News, Updates & Announcement
Delhi HC bars Natco Pharma from selling cancer drug Olaparib.The Delhi High Court has prohibited Natco Pharma from producing and selling the cancer drug Olaparib, marketed as 'BRACANAT' or under any other name, until further notice. The court's decision came in response to a lawsuit by Kudos Pharmaceuticals, which claimed that Natco was infringing on its patent for Olaparib. The court found Natco's challenge to the patent's validity unconvincing, leading to the injunction. Natco had sought to revoke Kudos' patent only after the lawsuit was filed, despite no previous opposition to it..
- Operations at Natco Pharma Chennai factory temporarily disrupted due to cyclone.
Hyderabad: Natco Pharma has announced that the operations at the Company's factory located at Manali Industrial Area, Chennai, Tamil Nadu have been temporarily disrupted due to cyclone with ... .
- Natco Pharma Q2 FY24 results: profit rise by 549.65% YOY | Mint.
Natco Pharma Q2 FY24 results: Revenue increased by 138.69% YoY & profit increased by 549.65% YoY.
- Pee Safe raises $3 million in a Series B funding round led by Natco Pharma and Rainmatter Health.
Hygiene and wellness brand Pee Safe has raised $3 million in a Series B funding round led by Natco Pharma Limited and Rainmatter Health. The funds will be used to expand the company's retail presence in India, expand overseas, and allocate additional resources to marketing and awareness initiatives. Pee Safe offers a range of personal hygiene products, including reusable pads, tampons, and menstrual cups, and aims to address the lack of access to safe menstrual and personal hygiene products for Indian women..
Frequently asked questions
What is the Incorporation or founding date of Natco Drug Discovery Private Limited?
Natco Drug Discovery Private Limited was incorporated on 02 May 1989.
What is authorized share capital and paid-up capital of Natco Drug Discovery Private Limited?
The authorized share capital of Natco Drug Discovery Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Natco Drug Discovery Private Limited?
Currently 2 directors are associated with Natco Drug Discovery Private Limited.
- Pathuri Srinivasa Rao
- Sadasiva Rao Nannapaneni
What is the registered address of Natco Drug Discovery Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Natco Drug Discovery Private Limited is Natco House, Road No.2 Banjarahills India, Hyderabad, Telangana, 500033.
What is the corporate identification number (CIN) and company number of Natco Drug Discovery Private Limited?
The corporate identification number (CIN) of Natco Drug Discovery Private Limited is U24230TG1989PTC009942 and the company number is 009942 as per Ministry of Corporate Affairs (MCA).
What is the official website of Natco Drug Discovery Private Limited?
The Official website of Natco Drug Discovery Private Limited is https://www.natcopharma.co.in
What change has been observed in the net worth of Natco Drug Discovery Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Natco Drug Discovery Private Limited has experienced an downturn of -0.01%.
When was the last Balance Sheet of Natco Drug Discovery Private Limited filed with the ROC?
The most recent Balance Sheet for Natco Drug Discovery Private Limited was filed with the ROC on 31 Mar 2024.
People also Viewed
SG
Satish GaddipatiDirector
Similar Companies Based on Drug Formulation & Development
Mylan Laboratories Limited Hyderabad, Telangana, India
Sun Pharma Laboratories Limited Mumbai, Maharashtra, India
Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
Lupin Limited Mumbai, Maharashtra, India
Alkem Laboratories Limited Mumbai, Maharashtra, India
Hetero Labs Limited Rangareddy, Telangana, India
Aurobindo Pharma Ltd Hyderabad, Telangana, India
Cipla Limited Mumbai, Maharashtra, India